Skip to content
IMKELDI Oral Solution by Shorla Oncology
  • IMKELDI v. Imatinib Tablets
  • Package Insert
  • Ordering
  • Patient Instructions
  • Patient Assistance

Sitemap

Pages

  • IMKELDI
  • Imkeldi Ordering
  • IMKELDI PATIENT INSTRUCTION VIDEO
  • Patient Access
  • Privacy Policy
  • Sitemap
  • Tablets
  • Test Popup

Products

  • Jylamvo-old

Jobs

  • Director of Sales Operations
  • Quality Assurance Specialist
  • Regulatory Affairs Officer
  • Technical Services Manager
  • Senior Analytical Specialist
  • Director of Medical Affairs

Pipelines

  • SH-201
  • SH-110
  • SH-105

Popups

  • Pediatrics Approved
  • Example: Auto-opening announcement popup
  • ASCO
  • Example: Auto-opening announcement popup

Popup Themes

  • Content Only - For use with page builders or block editor
  • Floating Bar - Soft Blue
  • Framed Border
  • Cutting Edge
  • Hello Box
  • Enterprise Blue
  • Light Box
  • Default Theme

Job Locations

  • Cambridge, MA, USA
  • Ireland

Job Categories

  • Commercial
  • Operations
  • Quality
  • Regulatory Affairs
  • Research & Development
  • Sales

IRELAND HQ:
Questum Acceleration Center,
Ballingarrane Science & Technology Park,
Clonmel, Co. Tipperary,
E91 V329, Ireland

SITEMAP
PRIVACY POLICY
Company number: 618033
©SHORLA ONCOLOGY® 2025

Shorla Pharma Ltd trading as Shorla Oncology®

 

All trademarks are the property of their respective owners.

US OFFICE:
245 Main St.,
2nd floor,
Cambridge,
MA 02142, USA

SITEMAP
PRIVACY POLICY
Company number: 618033
©SHORLA ONCOLOGY® 2025

© 2025 IMKELDI Oral Solution by Shorla Oncology • Built with GeneratePress
  • IMKELDI v. Imatinib Tablets
  • Package Insert
  • Ordering
  • Patient Instructions
  • Patient Assistance

Now approved for use in Pediatrics

  • Treatment of pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA).
  • Treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.

Please click here for the full Prescribing information, including Boxed Warning regarding embryo-fetal toxicity, hypersensitivity reactions, and severe adverse reactions.